AstraZeneca | AZN - Operating Profit



AstraZeneca reported $3.51B in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
AbbVie USD 5.72B 1.98B Jun/2025
Alcon AG USD 247M 221M Jun/2025
Almirall EUR 43.02M 8.82M Jun/2025
Amgen USD 2.66B 1.37B Jun/2025
argenx SE USD 203.84M 64.9M Jun/2025
AstraZeneca USD 3.51B 166M Jun/2025
Autolus Therapeutics Ltd -82608000 17.37M Jun/2025
Bayer EUR 13M 2.31B Jun/2025
Biogen USD 851.8M 540.6M Jun/2025
Bristol-Myers Squibb USD 3.77B 366M Jun/2025
Eli Lilly USD 7.02B 1.61B Jun/2025
Fresenius EUR 560M 127M Jun/2025
Fresenius Medical Care EUR 431M 100M Jun/2025
Galapagos EUR -57027000 101.68M Jun/2025
Genmab DKK 360M 172M Jun/2025
Gilead Sciences USD 2.7B 467M Jun/2025
GlaxoSmithKline GBP 2.02B 193M Jun/2025
GRIFOLS EUR 349.54M 80.68M Jun/2025
Haleon 608.5M 258.5M Jun/2025
Hikma Pharmaceutical USD 282M 45M Dec/2024
Lonza CHF 430M 104M Dec/2024
Merck EUR 1.03B 24M Jun/2025
Merck USD 6.36B 494M Jun/2025
Novartis USD 4.86B 201M Jun/2025
Orion EUR 104.6M 26.7M Jun/2025
Pfizer USD 2.6B 1.06B Jun/2025
Philips EUR 488M 334M Jun/2025
Recordati EUR 149.95M 45.82M Jun/2025
Regeneron Pharmaceuticals USD 1.08B 487.8M Jun/2025
Roche Holding CHF 4.39B 1.04B Dec/2024
Sanofi EUR 1.71B 573M Jun/2025
UCB EUR 1B 678M Dec/2024